Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2018

View Archived Issues

Kinase interplay prevents ALS

Parkin, PINK keep inflammation pout of the red zone

Brain-on-three-chips includes BBB

Unexpected asthma mechanism changes targeting calculus

Nilotinib improves biomarkers of Parkinson's disease in phase II study

Koligo introduces Kyslecel to preserve insulin secretory capacity after total pancreatectomy

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

EGFR tyrosine kinase inhibitor from UCLA crosses the blood-brain barrier

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

University of Michigan describes bromodomain and extra-terminal protein inhibitors

Seoul National University patents 4'-phosphopantetheinyl transferase inhibitors

G-0775: An arylomycin class Gram-negative antibiotic

Zai Lab discontinues development of ZL-3101 for atopic dermatitis

European Commission approves Vyxeos for two types of high-risk AML

Evotec and Centogene establish drug discovery collaboration in rare genetic diseases

European Commission approves Kymriah

Yescarta approved in E.U. for relapsed or refractory DLBCL and PMBCL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...